Pasar al contenido principal

GENERACION DE DATOS SINTETICOS, CONOCIMIENTO Y RECOMENDACIONES CLINICAS CON INTELIGENCIA ARTIFICIAL PARA LA MEJORA DE LAS TERAPIAS DE LA OREJUELA IZQUIERDA

PID2022-143239OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POMPEU FABRA CCT

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Contribución de congreso (ConferenceOutput)

Quantitative comparison of blood flow patterns from in silico simulations and 4D flow data before and after left atrial occlusion

  • Casademunt, Paula
  • Morales Ferez, Xabier
  • Cepas-Guillen, Pedro L.
  • Doltra, Ada
  • Mill, Jordi
  • Saiz-Vivó, Marta
  • Flores-Umanzor, Eduardo
  • Sanchis, Laura
  • Freixa, Xavier
  • Camara, Oscar
Atrial fibrillation (AF), the most common cardiac arrhythmia, increases the risk of thrombus, especially in the left atrial appendage (LAA). LAA occlusion (LAAO) reduces stroke risk in AF patients by isolating the LAA from the left atrium (LA). Computational fluid dynamics (CFD) simulations, offering superior resolution than current imaging techniques, are proposed to assess thrombus risk, but require validation. Emerging imaging techniques like 4D flow MRI provide in-vivo flow measurements supporting CFD credibility. Our dataset includes 4D flow magnetic resonance imaging (MRI), cardiac computational tomography (CT), and Doppler ultrasound (US) of the mitral valve for four patients (pre- and post-LAAO). We developed patient-specific CFD simulations from CT and US data, comparing blood flow patterns with 4D flow MRI. The analysis was focused on thrombus formation indicators, such as particle deposition, LAA washout, and endothelial cell activation potential (ECAP). Results from both data and simulations were within similar ranges but showed limited patient-wise agreement. Post-LAAO hemodynamic changes assessed by 4D flow MRI and CFD data agreed on reduced thrombogenic indices such as ECAP, flow stasis and vorticity. This study highlights the need for computational model validation, comparing CFD models with 4D flow MRI, being the first to quantitatively analyze 4D flow MRI data with implanted LAAO devices., This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement, No 101016496 (SimCardioTest) and No. 101136438 (GEMINI). We also acknowledge the support by the Spanish Ministry of Science, Innovation and Universities under the Proyectos the Generación del Conocimiento Programme (GENERALITAAT project, PIT2022-143239OB-I00). This work was also supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (grant No. 2024 FI-1 00419), and the Maria de Maeztu grant of excellence.
Repositorio Digital de la UPF
Publicación Contribución de congreso (ConferenceOutput)

Multi-therapeutic modelling for stroke prevention in atrial fibrillation: impact of the pulmonary ridge

  • Segarra-Queralt, Maria
  • Barrouhou Berrouhou, Manal
  • Molla, Marc
  • Ribera Pascual, Marina
  • Albors, Carlos
  • Olivares Miyares, Andy Luis
  • Bernardino Perez, Gabriel
  • Mill, Jordi
  • Camara, Oscar
Atrial Fibrillation affects 33.5 million people worldwide. It is associated with life-threatening consequences such as stroke, placing a heavy burden on healthcare resources. Stroke prevention is based on administering direct oral anticoagulants (DOACs) and for those contraindicated left atrial appendage occlusion (LAAO) is recommended. Still, after LAAO, a short-term period of anticoagulation is needed to avoid device-related thrombus. Predicting the minimal dose of anticoagulant administered after the intervention might reduce DOAC’s side effects. Therefore, we present a multi-therapeutic model that combines LAAO flow simulations with DOAC monitoring. Six simulations representing different clinical practice scenarios are performed: LAAO covering and uncovering the pulmonary ridge with or without 2.5 mg apixaban. Results show that applying 2.5 mg of Apixaban reduces the risk of DRT no matter the position of the occluder in the pulmonary ridge. Future steps should address the integration of more anticoagulant therapies. Despite being a proof-of-concept, we successfully developed a multi-therapeutic approach that evaluates the formation of DRT in different clinical scenarios., This study was funded by the Spanish Ministry of Science (GENERALITAAT: PID2022-143239OB-I00) and the European Union (GA 101136438- GEMINI and 101016496 Sim-CardioTest). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Agency. Neither the European Union nor the granting authority can be held responsible for them.
Repositorio Digital de la UPF
Publicación Contribución de congreso (ConferenceOutput)

Automatic identification of optimal transseptal puncture localization and device configuration with patient-specific haemodynamic modelling in patients undergoing left atrial appendage occlusion

  • Saiz-Vivó, Marta
  • Mill, Jordi
  • Aguado, Ainhoa M.
  • Rochelle, Nahomy
  • Barredo, Anna
  • Albors Lucas, Carlos
  • Font Murillo, Mònica
  • Cepas-Guillen, Pedro L.
  • Freixa, Xavier
  • Barreiro-Perez, Manuel
  • Camara, Oscar
Atrial Fibrillation affects 33.5 million people worldwide. It is associated with life-threatening consequences such as stroke, placing a heavy burden on healthcare resources. Stroke prevention is based on administering direct oral anticoagulants (DOACs) and for those contraindicated left atrial appendage occlusion (LAAO) is recommended. Still, after LAAO, a short-term period of anticoagulation is needed to avoid device-related thrombus. Predicting the minimal dose of anticoagulant administered after the intervention might reduce DOAC’s side effects. Therefore, we present a multi-therapeutic model that combines LAAO flow simulations with DOAC monitoring. Six simulations representing different clinical practice scenarios are performed: LAAO covering and uncovering the pulmonary ridge with or without 2.5 mg apixaban. Results show that applying 2.5 mg of Apixaban reduces the risk of DRT no matter the position of the occluder in the pulmonary ridge. Future steps should address the integration of more anticoagulant therapies. Despite being a proof-of-concept, we successfully developed a multi-therapeutic approach that evaluates the formation of DRT in different clinical scenarios., This study was funded by the Spanish Ministry of Science (GENERALITAAT: PID2022-143239OB-I00) and the European Union (GA 101136438- GEMINI and 101016496 Sim-CardioTest). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Agency. Neither the European Union nor the granting authority can be held responsible for them.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Automatic identification of optimal transseptal puncture localization and device configuration with patient-specific haemodynamic modelling in patients undergoing left atrial appendage occlusion

  • Saiz-Vivó, Marta
  • Mill, Jordi
  • Aguado, Ainhoa M.
  • Rochelle, Nahomy
  • Barredo, Anna
  • Albors Lucas, Carlos
  • Font Murillo, Mònica
  • Cepas-Guillen, Pedro L.
  • Freixa, Xavier
  • Barreiro-Perez, Manuel
  • Camara, Oscar
Atrial Fibrillation affects 33.5 million people worldwide. It is associated with life-threatening consequences such as stroke, placing a heavy burden on healthcare resources. Stroke prevention is based on administering direct oral anticoagulants (DOACs) and for those contraindicated left atrial appendage occlusion (LAAO) is recommended. Still, after LAAO, a short-term period of anticoagulation is needed to avoid device-related thrombus. Predicting the minimal dose of anticoagulant administered after the intervention might reduce DOAC’s side effects. Therefore, we present a multi-therapeutic model that combines LAAO flow simulations with DOAC monitoring. Six simulations representing different clinical practice scenarios are performed: LAAO covering and uncovering the pulmonary ridge with or without 2.5 mg apixaban. Results show that applying 2.5 mg of Apixaban reduces the risk of DRT no matter the position of the occluder in the pulmonary ridge. Future steps should address the integration of more anticoagulant therapies. Despite being a proof-of-concept, we successfully developed a multi-therapeutic approach that evaluates the formation of DRT in different clinical scenarios., This study was funded by the Spanish Ministry of Science (GENERALITAAT: PID2022-143239OB-I00) and the European Union (GA 101136438- GEMINI and 101016496 Sim-CardioTest). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Agency. Neither the European Union nor the granting authority can be held responsible for them.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Quantitative comparison of blood flow patterns from in silico simulations and 4D flow data before and after left atrial occlusion

  • Casademunt, Paula
  • Morales Ferez, Xabier
  • Cepas-Guillen, Pedro L.
  • Doltra, Ada
  • Mill, Jordi
  • Saiz-Vivó, Marta
  • Flores-Umanzor, Eduardo
  • Sanchis, Laura
  • Freixa, Xavier
  • Camara, Oscar
Atrial fibrillation (AF), the most common cardiac arrhythmia, increases the risk of thrombus, especially in the left atrial appendage (LAA). LAA occlusion (LAAO) reduces stroke risk in AF patients by isolating the LAA from the left atrium (LA). Computational fluid dynamics (CFD) simulations, offering superior resolution than current imaging techniques, are proposed to assess thrombus risk, but require validation. Emerging imaging techniques like 4D flow MRI provide in-vivo flow measurements supporting CFD credibility. Our dataset includes 4D flow magnetic resonance imaging (MRI), cardiac computational tomography (CT), and Doppler ultrasound (US) of the mitral valve for four patients (pre- and post-LAAO). We developed patient-specific CFD simulations from CT and US data, comparing blood flow patterns with 4D flow MRI. The analysis was focused on thrombus formation indicators, such as particle deposition, LAA washout, and endothelial cell activation potential (ECAP). Results from both data and simulations were within similar ranges but showed limited patient-wise agreement. Post-LAAO hemodynamic changes assessed by 4D flow MRI and CFD data agreed on reduced thrombogenic indices such as ECAP, flow stasis and vorticity. This study highlights the need for computational model validation, comparing CFD models with 4D flow MRI, being the first to quantitatively analyze 4D flow MRI data with implanted LAAO devices., This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement, No 101016496 (SimCardioTest) and No. 101136438 (GEMINI). We also acknowledge the support by the Spanish Ministry of Science, Innovation and Universities under the Proyectos the Generación del Conocimiento Programme (GENERALITAAT project, PIT2022-143239OB-I00). This work was also supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (grant No. 2024 FI-1 00419), and the Maria de Maeztu grant of excellence.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Multi-therapeutic modelling for stroke prevention in atrial fibrillation: impact of the pulmonary ridge

  • Segarra-Queralt, Maria
  • Barrouhou Berrouhou, Manal
  • Molla, Marc
  • Ribera Pascual, Marina
  • Albors, Carlos
  • Olivares Miyares, Andy Luis
  • Bernardino Perez, Gabriel
  • Mill, Jordi
  • Camara, Oscar
Atrial Fibrillation affects 33.5 million people worldwide. It is associated with life-threatening consequences such as stroke, placing a heavy burden on healthcare resources. Stroke prevention is based on administering direct oral anticoagulants (DOACs) and for those contraindicated left atrial appendage occlusion (LAAO) is recommended. Still, after LAAO, a short-term period of anticoagulation is needed to avoid device-related thrombus. Predicting the minimal dose of anticoagulant administered after the intervention might reduce DOAC’s side effects. Therefore, we present a multi-therapeutic model that combines LAAO flow simulations with DOAC monitoring. Six simulations representing different clinical practice scenarios are performed: LAAO covering and uncovering the pulmonary ridge with or without 2.5 mg apixaban. Results show that applying 2.5 mg of Apixaban reduces the risk of DRT no matter the position of the occluder in the pulmonary ridge. Future steps should address the integration of more anticoagulant therapies. Despite being a proof-of-concept, we successfully developed a multi-therapeutic approach that evaluates the formation of DRT in different clinical scenarios., This study was funded by the Spanish Ministry of Science (GENERALITAAT: PID2022-143239OB-I00) and the European Union (GA 101136438- GEMINI and 101016496 Sim-CardioTest). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Agency. Neither the European Union nor the granting authority can be held responsible for them.